Showing results (251-260 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|March 1, 2006
Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2Carolyn Cao, Eric T Shinohara, Ty K Subhawong, et al.
Molecular Cancer Therapeutics|March 1, 2006
The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell lineShrikanta Chattopadhyay, Rongbao Zhao, Sergey A Krupenko, et al.
Molecular Cancer Therapeutics|January 25, 2006
Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptidePatrick B Senatus, Yin Li, Christopher Mandigo, et al.
Molecular Cancer Therapeutics|January 25, 2006
Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcuminGuoxiang Shen, Changjiang Xu, Rong Hu, et al.
Molecular Cancer Therapeutics|January 25, 2006
Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acidTadashi Ikegami, Yasushi Matsuzaki, Maryam Al Rashid, et al.
Molecular Cancer Therapeutics|January 25, 2006
Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cellsAparecida Maria Fontes, Brian M Davis, Lance P Encell, et al.
Molecular Cancer Therapeutics|January 25, 2006
Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cellsSeiji Kondo, Noriko Tanaka, Satoshi Kubota, et al.
Molecular Cancer Therapeutics|March 21, 2006
Targeted therapy by disabling crossroad signaling networks: the survivin paradigmDario C Altieri
Molecular Cancer Therapeutics|March 21, 2006
Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cellsZhiwei Wang, Yuxiang Zhang, Yiwei Li, et al.
Molecular Cancer Therapeutics|March 21, 2006
Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cellsYasuhiro Arakawa, Hideaki Suzuki, Shinobu Saito, et al.
Pageof 601